Cann American Corp. acquired Prodigy Stem Cell, LLC.
Cann American Corp. (OTCPK:CNNA) completed the acquisition of Prodigy Stem Cell, LLC on March 1, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | +50.00% | +25.00% | -25.00% |
2023 | Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023 | CI |
2023 | Cann American Corp. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-25.00% | 2.21M | |
+28.84% | 684B | |
+29.74% | 568B | |
-3.83% | 361B | |
+17.82% | 329B | |
+4.49% | 284B | |
+16.02% | 240B | |
+9.38% | 208B | |
-6.67% | 200B | |
+7.58% | 166B |